Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Perrigo Co (PRGO) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Perrigo Co. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 820096.
Total stock buying since 2010: $31,294,881.
Total stock sales since 2010: $433,912,978.
Total stock option exercises since 2010: $59,885,384.
▪ Statistics of price movements of PRGO
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2013 | 0 | $0 | 364,178 | $49,906,784 | 187,900 | $10,571,242 |
2012 | 296,000 | $31,016,360 | 577,985 | $60,600,095 | 399,326 | $24,294,843 |
2011 | 2,898 | $278,521 | 3,376,023 | $270,396,202 | 541,497 | $21,086,955 |
2010 | 0 | $0 | 837,326 | $53,009,897 | 272,973 | $3,932,344 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2011-06-03 | Yu Louis (Senior VP Global Quality) | Option Ex | 1,796 | 30.06 | 53,987 |
2011-06-03 | Lebel Refael (EVP & GM Perrigo Israel) | Sale | 2,215 | 84.65 | 187,499 |
2011-05-31 | Brlas Laurie (Director) | Sale | 5,814 | 85.11 | 494,841 |
2011-05-31 | Brlas Laurie (Director) | Option Ex | 5,814 | 16.77 | 97,500 |
2011-05-20 | Arkin Moshe (Director) | Sale | 400 | 87.00 | 34,800 |
2011-05-19 | Shah Jatin (Sr VP & Chief Scientific Offic) | Sale | 2,000 | 86.92 | 173,836 |
2011-05-19 | Shah Jatin (Sr VP & Chief Scientific Offic) | Option Ex | 2,000 | 14.69 | 29,380 |
2011-05-19 | Arkin Moshe (Director) | Sale | 37,557 | 87.04 | 3,268,998 |
2011-05-18 | Arkin Moshe (Director) | Sale | 142,805 | 86.31 | 12,325,927 |
2011-05-13 | Arkin Moshe (Director) | Sale | 7,195 | 87.78 | 631,591 |
2011-05-12 | Arkin Moshe (Director) | Sale | 100,000 | 87.43 | 8,742,600 |
2011-05-11 | Arkin Moshe (Director) | Sale | 50,175 | 87.24 | 4,377,317 |
2011-05-10 | Arkin Moshe (Director) | Sale | 78,553 | 87.52 | 6,874,644 |
2011-05-09 | Stewart Michael Robert (Sr. VP Global Human Resources) | Sale | 3,731 | 87.00 | 324,597 |
2011-05-09 | Stewart Michael Robert (Sr. VP Global Human Resources) | Option Ex | 3,731 | 14.69 | 54,808 |
2011-05-09 | Needham Jeffrey (Sr. VP Commercial Business Dev) | Sale | 11,318 | 86.79 | 982,266 |
2011-05-09 | Arkin Moshe (Director) | Sale | 141,127 | 87.63 | 12,366,535 |
2011-05-09 | Kingma Todd W (Executive VP, General Counsel) | Sale | 6,300 | 87.57 | 551,691 |
2011-05-09 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 6,000 | 30.06 | 180,360 |
2011-05-09 | Kunkle Gary K Jr (Director) | Sale | 5,000 | 88.00 | 440,000 |
2011-05-09 | Kunkle Gary K Jr (Director) | Option Ex | 5,000 | 11.83 | 59,150 |
2011-05-06 | Arkin Moshe (Director) | Sale | 65,095 | 87.43 | 5,691,125 |
2011-05-05 | Arkin Moshe (Director) | Sale | 165,050 | 86.03 | 14,199,581 |
2011-05-04 | Hendrickson John T (EVP Global Operations & Supply) | Sale | 15,000 | 87.01 | 1,305,135 |
2011-04-25 | Papa Joseph C (President and CEO) | Sale | 21,000 | 88.81 | 1,865,031 |
2011-04-25 | Papa Joseph C (President and CEO) | Option Ex | 15,000 | 20.50 | 307,500 |
2011-03-22 | Papa Joseph C (President and CEO) | Sale | 21,000 | 76.36 | 1,603,560 |
2011-03-22 | Papa Joseph C (President and CEO) | Option Ex | 15,000 | 18.89 | 283,425 |
2011-03-03 | Arkin Moshe (Director) | Sale | 22,099 | 77.38 | 1,709,976 |
2011-03-02 | Kochan Sharon (Executive VP U.S. Generics) | Sale | 7,500 | 76.38 | 572,820 |
2011-03-02 | Kochan Sharon (Executive VP U.S. Generics) | Option Ex | 7,500 | 15.08 | 113,100 |
2011-03-02 | Arkin Moshe (Director) | Sale | 77,901 | 76.67 | 5,972,513 |
2011-03-02 | Jandernoa Michael J (Director) | Sale | 3,942 | 76.46 | 301,389 |
2011-03-02 | Jandernoa Michael J (Director) | Option Ex | 3,942 | 14.12 | 55,661 |
2011-03-01 | Arkin Moshe (Director) | Sale | 50,000 | 76.77 | 3,838,550 |
2011-02-28 | Arkin Moshe (Director) | Sale | 84,513 | 76.18 | 6,437,862 |
2011-02-28 | Arkin Moshe (Director) | Option Ex | 34,513 | 24.95 | 860,961 |
2011-02-25 | Arkin Moshe (Director) | Sale | 43,874 | 75.55 | 3,314,549 |
2011-02-22 | Arkin Moshe (Director) | Sale | 56,126 | 74.94 | 4,205,801 |
2011-02-22 | Papa Joseph C (President and CEO) | Sale | 21,000 | 74.94 | 1,573,781 |
2011-02-22 | Papa Joseph C (President and CEO) | Option Ex | 15,000 | 17.29 | 259,350 |
2011-02-18 | Brown Judy L (Executive VP & CFO) | Sale | 2,000 | 75.84 | 151,682 |
2011-02-18 | Arkin Moshe (Director) | Sale | 200,000 | 75.69 | 15,138,399 |
2011-02-17 | Arkin Moshe (Director) | Sale | 87,651 | 76.05 | 6,665,507 |
2011-02-16 | Shah Jatin (Sr VP & Chief Scientific Offic) | Sale | 2,000 | 74.58 | 149,166 |
2011-02-16 | Arkin Moshe (Director) | Sale | 200,000 | 75.66 | 15,131,800 |
2011-02-16 | Kingma Todd W (Executive VP, General Counsel) | Sale | 4,000 | 74.56 | 298,240 |
2011-02-16 | Hendrickson John T (EVP Global Operations & Supply) | Sale | 5,000 | 75.06 | 375,305 |
2011-02-15 | Jandernoa Michael J (Director) | Sale | 33,184 | 73.67 | 2,444,798 |
2011-02-14 | Kochan Sharon (Executive VP U.S. Generics) | Sale | 2,588 | 73.90 | 191,253 |
2011-02-14 | Kochan Sharon (Executive VP U.S. Generics) | Option Ex | 2,588 | 35.85 | 92,779 |
2011-02-14 | Jandernoa Michael J (Director) | Sale | 30,000 | 74.07 | 2,222,160 |
2011-02-11 | Needham Jeffrey (Sr. VP Commercial Business Dev) | Sale | 6,893 | 73.17 | 504,333 |
2011-02-11 | Needham Jeffrey (Sr. VP Commercial Business Dev) | Option Ex | 3,893 | 14.69 | 57,188 |
2011-02-11 | Farrington Thomas (Senior VP and CIO) | Sale | 3,391 | 71.77 | 243,372 |
2011-02-11 | Farrington Thomas (Senior VP and CIO) | Option Ex | 3,391 | 32.95 | 111,750 |
2011-02-11 | Gottfried Ran (Director) | Sale | 5,814 | 73.07 | 424,846 |
2011-02-11 | Gottfried Ran (Director) | Option Ex | 5,814 | 16.77 | 97,500 |
2011-02-11 | Lebel Refael (EVP & GM Perrigo Israel) | Sale | 3,596 | 71.90 | 258,552 |
2011-02-11 | Lebel Refael (EVP & GM Perrigo Israel) | Option Ex | 3,596 | 35.85 | 128,916 |
2011-02-11 | Morris Herman Jr (Director) | Sale | 3,942 | 73.47 | 289,618 |
2011-02-11 | Morris Herman Jr (Director) | Option Ex | 3,942 | 14.12 | 55,661 |
2011-02-11 | Jandernoa Michael J (Director) | Sale | 12,000 | 72.48 | 869,760 |
2011-02-10 | Lebel Refael (EVP & GM Perrigo Israel) | Sale | 14,973 | 71.87 | 1,076,079 |
2011-02-10 | Lebel Refael (EVP & GM Perrigo Israel) | Option Ex | 12,161 | 17.59 | 213,972 |
2011-02-10 | Jandernoa Michael J (Director) | Sale | 210,903 | 71.94 | 15,172,150 |
2011-02-09 | Jandernoa Michael J (Director) | Sale | 116,779 | 71.77 | 8,381,695 |
2011-02-08 | Kochan Sharon (Executive VP U.S. Generics) | Sale | 3,117 | 71.90 | 224,112 |
2011-02-08 | Lebel Refael (EVP & GM Perrigo Israel) | Sale | 2,786 | 71.91 | 200,341 |
2011-02-08 | Jandernoa Michael J (Director) | Sale | 80,000 | 71.64 | 5,730,960 |
2011-02-07 | Brown Judy L (Executive VP & CFO) | Sale | 21,978 | 71.39 | 1,568,899 |
2011-02-07 | Brown Judy L (Executive VP & CFO) | Option Ex | 21,978 | 25.27 | 555,493 |
2011-02-07 | Lebel Refael (EVP & GM Perrigo Israel) | Sale | 420 | 71.53 | 30,042 |
2011-02-07 | Jandernoa Michael J (Director) | Sale | 104,134 | 71.80 | 7,476,508 |
2011-02-04 | Kochan Sharon (Executive VP U.S. Generics) | Sale | 5,607 | 72.00 | 403,704 |
2011-02-04 | Kochan Sharon (Executive VP U.S. Generics) | Option Ex | 5,607 | 25.28 | 141,744 |
2011-02-04 | Jandernoa Michael J (Director) | Sale | 108,000 | 71.81 | 7,755,156 |
2011-02-03 | Brlas Laurie (Director) | Sale | 5,000 | 70.78 | 353,895 |
2011-02-03 | Brlas Laurie (Director) | Option Ex | 5,000 | 14.99 | 74,975 |
2011-02-03 | Cohen Gary M (Director) | Sale | 5,814 | 71.71 | 416,910 |
2011-02-03 | Cohen Gary M (Director) | Option Ex | 5,814 | 16.77 | 97,500 |
2011-02-03 | Jandernoa Michael J (Director) | Sale | 160,000 | 71.55 | 11,447,360 |
2011-02-02 | Kingma Todd W (Executive VP, General Counsel) | Sale | 15,366 | 72.89 | 1,120,104 |
2011-02-02 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 14,766 | 17.59 | 259,807 |
2011-02-02 | Hendrickson John T (EVP Global Operations & Supply) | Sale | 53,564 | 73.18 | 3,919,867 |
2011-02-02 | Hendrickson John T (EVP Global Operations & Supply) | Option Ex | 53,564 | 22.46 | 1,202,940 |
2011-02-02 | Jandernoa Michael J (Director) | Sale | 145,000 | 73.28 | 10,625,310 |
2010-09-01 | Shah Jatin (Sr VP & Chief Scientific Offic) | Sale | 9,877 | 57.99 | 572,757 |
2010-09-01 | Shah Jatin (Sr VP & Chief Scientific Offic) | Option Ex | 9,877 | 25.47 | 251,567 |
2010-09-01 | Yu Louis (Senior VP Global Quality) | Sale | 1,664 | 58.18 | 96,806 |
2010-09-01 | Yu Louis (Senior VP Global Quality) | Option Ex | 1,664 | 20.50 | 34,112 |
2010-09-01 | Farrington Thomas (Senior VP and CIO) | Sale | 1,114 | 57.81 | 64,400 |
2010-09-01 | Farrington Thomas (Senior VP and CIO) | Option Ex | 1,114 | 20.50 | 22,837 |
2010-09-01 | Kochan Sharon (Executive VP U.S. Generics) | Sale | 3,600 | 58.24 | 209,664 |
2010-09-01 | Lebel Refael (EVP & GM Perrigo Israel) | Sale | 3,042 | 58.21 | 177,074 |
2010-09-01 | Jandernoa Michael J (Director) | Sale | 10,613 | 58.04 | 615,978 |
2010-09-01 | Jandernoa Michael J (Director) | Option Ex | 10,613 | 6.56 | 69,653 |
2010-08-31 | Stewart Michael Robert (Sr. VP Global Human Resources) | Sale | 11,931 | 57.50 | 686,032 |
2010-08-31 | Stewart Michael Robert (Sr. VP Global Human Resources) | Option Ex | 6,931 | 25.47 | 176,532 |
2010-08-31 | Needham Jeffrey (Sr. VP Commercial Business Dev) | Sale | 1,030 | 57.21 | 58,927 |
2010-08-31 | Kingma Todd W (Executive VP, General Counsel) | Sale | 4,500 | 57.21 | 257,454 |
2010-08-30 | Shah Jatin (Sr VP & Chief Scientific Offic) | Option Ex | 3,512 | .00 | 0 |
2010-08-30 | Stewart Michael Robert (Sr. VP Global Human Resources) | Option Ex | 2,195 | .00 | 0 |
2010-08-30 | Yu Louis (Senior VP Global Quality) | Option Ex | 2,341 | .00 | 0 |
2010-08-30 | Needham Jeffrey (Sr. VP Commercial Business Dev) | Sale | 20,508 | 57.89 | 1,187,208 |
2010-08-30 | Needham Jeffrey (Sr. VP Commercial Business Dev) | Option Ex | 18,669 | 20.38 | 380,399 |
2010-08-30 | Farrington Thomas (Senior VP and CIO) | Sale | 842 | 58.08 | 48,903 |
2010-08-30 | Farrington Thomas (Senior VP and CIO) | Option Ex | 3,593 | 10.25 | 36,828 |
2010-08-30 | Kochan Sharon (Executive VP U.S. Generics) | Option Ex | 4,098 | .00 | 0 |
2010-08-30 | Brown Judy L (Executive VP & CFO) | Option Ex | 7,537 | .00 | 0 |
2010-08-30 | Arkin Moshe (Director) | Option Ex | 6,146 | .00 | 0 |
2010-08-30 | Lebel Refael (EVP & GM Perrigo Israel) | Sale | 5,854 | 58.15 | 340,427 |
2010-08-30 | Lebel Refael (EVP & GM Perrigo Israel) | Option Ex | 5,854 | .00 | 0 |
2010-08-30 | Kingma Todd W (Executive VP, General Counsel) | Sale | 6,497 | 57.74 | 375,149 |
2010-08-30 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 14,326 | 11.99 | 171,768 |
2010-08-30 | Papa Joseph C (President and CEO) | Option Ex | 29,268 | .00 | 0 |
2010-08-30 | Hendrickson John T (EVP Global Operations & Supply) | Option Ex | 5,049 | .00 | 0 |
2010-08-27 | Brown Judy L (Executive VP & CFO) | Sale | 11,163 | 57.84 | 645,656 |
2010-08-27 | Brown Judy L (Executive VP & CFO) | Option Ex | 5,163 | 15.47 | 79,871 |
2010-08-27 | Lebel Refael (EVP & GM Perrigo Israel) | Sale | 4,000 | 57.99 | 231,964 |
2010-08-27 | Lebel Refael (EVP & GM Perrigo Israel) | Option Ex | 4,000 | 15.47 | 61,880 |
2010-08-25 | Farrington Thomas (Senior VP and CIO) | Sale | 3,532 | 57.48 | 203,019 |
2010-05-27 | Stewart Michael Robert (Sr. VP Global Human Resources) | Sale | 6,000 | 60.09 | 360,570 |
2010-05-27 | Brown Judy L (Executive VP & CFO) | Sale | 11,420 | 60.14 | 686,821 |
2010-05-27 | Brown Judy L (Executive VP & CFO) | Option Ex | 11,420 | 28.18 | 321,758 |
2010-05-17 | Farrington Thomas (Senior VP and CIO) | Sale | 3,912 | 59.83 | 234,038 |
2010-05-17 | Farrington Thomas (Senior VP and CIO) | Option Ex | 3,316 | 35.85 | 118,878 |
2010-05-14 | Yu Louis (Senior VP Global Quality) | Sale | 6,660 | 61.12 | 407,038 |
2010-05-14 | Yu Louis (Senior VP Global Quality) | Option Ex | 6,660 | 20.50 | 136,530 |
2010-05-12 | Morris Herman Jr (Director) | Sale | 10,613 | 64.24 | 681,800 |
2010-05-12 | Morris Herman Jr (Director) | Option Ex | 10,613 | 6.56 | 69,653 |
2010-05-12 | Gibbons David T (Director) | Sale | 650,000 | 64.34 | 41,820,350 |
2010-05-12 | Gibbons David T (Director) | Option Ex | 65,000 | 18.18 | 1,181,700 |
2010-05-11 | Kochan Sharon (Executive VP U.S. Generics) | Sale | 2,588 | 62.74 | 162,371 |
2010-05-11 | Kochan Sharon (Executive VP U.S. Generics) | Option Ex | 2,588 | 35.85 | 92,779 |
2010-05-11 | Lebel Refael (EVP & GM Perrigo Israel) | Sale | 26,062 | 62.12 | 1,619,101 |
2010-05-11 | Lebel Refael (EVP & GM Perrigo Israel) | Option Ex | 11,920 | 28.18 | 335,846 |
2010-05-11 | Kingma Todd W (Executive VP, General Counsel) | Sale | 14,518 | 63.05 | 915,287 |
2010-05-11 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 14,518 | 18.05 | 262,049 |
2010-05-06 | Lebel Refael (EVP & GM Perrigo Israel) | Sale | 500 | 61.13 | 30,565 |
Insider trading activities including stock purchases, stock sales, and option exercises of PRGO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Perrigo Co (symbol PRGO, CIK number 820096) see the Securities and Exchange Commission (SEC) website.